| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 4.375 | 711 | 124 | 734 | 61.890 | 7.102 | 3.234 | 50.695 | 19.812 | 5.596 |
| Total Income - EUR | 8.752 | 1.546 | 3.107 | 2.453 | 61.890 | 7.102 | 3.245 | 50.695 | 19.812 | 5.596 |
| Total Expenses - EUR | 9.321 | 5.623 | 7.029 | 339 | 31.092 | 11.968 | 1.418 | 20.583 | 18.404 | 1.849 |
| Gross Profit/Loss - EUR | -569 | -4.077 | -3.922 | 2.114 | 30.798 | -4.866 | 1.827 | 30.112 | 1.408 | 3.747 |
| Net Profit/Loss - EUR | -832 | -4.098 | -3.978 | 2.040 | 30.179 | -4.930 | 1.731 | 29.666 | 1.210 | 3.577 |
| Employees | 0 | 0 | 0 | 0 | 5 | 1 | 0 | 5 | 2 | 0 |
Check the financial reports for the company - Neoltiprix S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.742 | 7.166 | 129 | 0 | 19 | 0 | 0 | 26.773 | 26.692 | 26.542 |
| Current Assets | 1.029 | 808 | 3.758 | 5.913 | 32.291 | 1.177 | 1.481 | 17.743 | 7.387 | 12.569 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 1.078 | 91 | 890 | 873 | 45 | 10.139 | 0 | 4.033 |
| Cash | 1.029 | 808 | 2.681 | 5.822 | 31.401 | 304 | 1.436 | 7.604 | 7.387 | 8.536 |
| Shareholders Funds | 4.547 | 402 | -3.583 | -1.477 | 28.899 | -353 | 1.386 | 31.056 | 32.172 | 35.569 |
| Social Capital | 45 | 45 | 44 | 43 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 7.224 | 7.572 | 7.471 | 7.390 | 3.410 | 1.530 | 95 | 13.460 | 2.048 | 3.543 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1722 - 1722" | |||||||||
| CAEN Financial Year |
125
|
|||||||||
Comments - Neoltiprix S.r.l.